Home Newsfeeds Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences Q2 EPS $(0.12)

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

byMichael Horton

August 15, 2022

1 minute read

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.12) per share.

ePlus Announces New Stock Repurchase Program Of Up To 1M Shares Over A 12-Month Period

By Happy Mohamed

April 5, 8:40 AM

ePlus inc. (NASDAQ NQGS: PLUS – news) today announced that its board of directors has authorized the Company to repurchase up to 1,000,000 shares of ePlus' outstanding common stock over a

PLUS

Stephens & Co. Maintains Overweight on Guardant Health, Lowers Price Target to $90

By Benzinga Newsdesk

November 7, 11:34 AM

Stephens & Co. analyst Mason Carrico maintains Guardant Health (NASDAQ:GH) with a Overweight and lowers the price target from $99 to $90.

Here’s How Much $1000 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

By Benzinga Insights

July 15, 11:03 AM

Meta Platforms (NASDAQ:META) has outperformed the market over the past 10 years by 8.02% on an annualized basis producing an average annual return of 18.79%. Currently, Meta Platforms has a market capitalization of $439.22 billion.

China’s Dip Weighs Asia Markets Lower, Europe Rises, Gold Tops $2,050 – Global Markets Today While US Was Sleeping

By Akanksha Bakshi

January 30, 8:24 AM

US stocks close higher on earnings reports & economic data. Japan's Nikkei gains 0.05%. China & Hong Kong hit multi-year lows amid economic concerns.

ADIV

Revelation Biosciences Q2 EPS $(0.12)

Related Posts

ePlus Announces New Stock Repurchase Program Of Up To 1M Shares Over A 12-Month Period

Stephens & Co. Maintains Overweight on Guardant Health, Lowers Price Target to $90

Here’s How Much $1000 Invested In Meta Platforms 10 Years Ago Would Be Worth Today

China’s Dip Weighs Asia Markets Lower, Europe Rises, Gold Tops $2,050 – Global Markets Today While US Was Sleeping